Form 4 Tracker
Travere Therapeutics, Inc.
TVTX

37 insider filings · Latest: May 5, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 11, 2025Feb 11 9:08 PMSANDRA CALVIN
Proposed Sale
54,244$25.00$1.4M

View →

Feb 11, 2025Feb 11 9:04 PMPETER HEERMA
Proposed Sale
3,074$25.00$76.8K

View →

Feb 11, 2025Feb 11 4:56 PMDube Eric M
Proposed Sale
11,375$24.04$273.5K

View →

Feb 6, 2025Feb 6 9:21 PMROY D BAYNES
Proposed Sale
10,000$22.00$220.0K

View →

Feb 4, 2025Feb 4 9:11 PMJULA INRIG
Proposed Sale
1,066$20.11$21.4K

View →

Feb 3, 2025Feb 4 1:47 AMPeter Heerma
Proposed Sale
5,166$20.12$103.9K

View →

Feb 3, 2025Feb 4 1:46 AMChristopher Cline
Proposed Sale
5,192$20.12$104.5K

View →

Feb 3, 2025Feb 4 1:41 AMSandra Calvin
Proposed Sale
3,348$20.12$67.4K

View →

Feb 3, 2025Feb 4 1:40 AMJula Inrig
Proposed Sale
4,207$20.12$84.6K

View →

Feb 3, 2025Feb 3 5:26 PMREED ELIZABETH E
Proposed Sale
8,951$19.78$177.1K

View →

Feb 3, 2025Feb 3 4:22 PMDube Eric M
Proposed Sale
50,691$19.78$1.0M

View →

Feb 3, 2025Feb 3 4:11 PMROTE WILLIAM E.
Proposed Sale
8,951$19.78$177.1K

View →

Jan 23, 2025Jan 23 9:14 PMROY D BAYNES
Proposed Sale
16,000$20.00$320.0K

View →

Jan 22, 2025Jan 22 3:34 PMDube Eric M
Proposed Sale
10,736$19.46$208.9K

View →

Jan 22, 2025Jan 22 3:18 PMREED ELIZABETH E
Proposed Sale
2,437$19.46$47.4K

View →

Jan 22, 2025Jan 22 2:36 PMROTE WILLIAM E.
Proposed Sale
2,437$19.46$47.4K

View →

Dec 26, 2024Dec 26 9:13 PMSANDRA CALVIN
Proposed Sale
15,000$17.22$258.3K

View →

Nov 25, 2024Nov 25 10:59 PMCalvin Sandra
Proposed Sale
12,090$18.30$221.3K

View →

Oct 4, 2024Oct 4 8:21 PMGARY A LYONS
Proposed Sale
40,000$13.65$546.0K

View →

Sep 30, 2024Sep 30 8:22 PMJEFFREY MECKLER
Proposed Sale
40,000$14.06$562.3K

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
May 5, 2026May 7 12:00 AMRoy D. BaynesDirector
Option Exercise
4,500$18.270(D)

View →

May 4, 2026May 7 12:00 AMMeckler Jeffrey ADirector
Option Exercise
8,000$16.330(D)

View →

May 4, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMWilliam E. RoteChief Research Officer
Option Exercise
4,2504,250(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMElizabeth E ReedChief Legal Officer and GC
Option Exercise
24,250$17.964,250(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMJula InrigCHIEF MEDICAL OFFICER
Option Exercise
24,250$22.404,250(D)

View →

May 4, 2026May 7 12:00 AMPeter HeermaCHIEF COMMERCIAL OFFICER
Grant/Award
8,5008,500(D)

View →

May 4, 2026May 7 12:00 AMPeter HeermaCHIEF COMMERCIAL OFFICER
Option Exercise
4,2504,250(D)

View →

May 4, 2026May 7 12:00 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Grant/Award
45,00045,000(D)

View →

May 4, 2026May 7 12:00 AMEric M DubeDirector, CHIEF EXECUTIVE OFFICER
Option Exercise
22,50022,500(D)

View →

May 4, 2026May 7 12:00 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Option Exercise
4,2504,250(D)

View →

May 4, 2026May 7 12:00 AMChristopher R. ClineCHIEF FINANCIAL OFFICER
Grant/Award
8,5008,500(D)

View →

May 1, 2026May 4 8:27 PMRoy D. BaynesDirector
Option Exercise
9,750$6.829,750(D)

View →

Apr 14, 2026Apr 16 8:05 PMLYONS GARY ADirector
Option Exercise
8,000$16.330(D)

View →

Apr 14, 2026Apr 16 8:05 PMRoy D. BaynesDirector
Option Exercise
32,750$21.386,750(D)

View →

Apr 14, 2026Apr 16 8:05 PMSandra CalvinSVP, CHIEF ACCOUNTING OFFICER
Option Exercise
15,250$22.4019,500(D)

View →

Apr 14, 2026Apr 16 1:47 AMElizabeth E ReedChief Legal Officer and GC
Option Exercise
37,500$19.0820,000(D)

View →

Apr 6, 2026Apr 7 10:17 PMRoy D. BaynesDirector
Option Exercise
10,000$26.520(D)

View →

Page 1 of 2

Next →